Avantor, Inc. Selling, General and Administrative Expense
Avantor, Inc. (AVTR) reported Selling, General and Administrative Expense of $401.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-04-29
- Avantor, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $401.20M, a 3.54% increase year-over-year.
- Avantor, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $392.40M, a 5.65% increase year-over-year.
- Avantor, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $390.30M, a 11.26% decline year-over-year.
- Avantor, Inc. selling, general and administrative expense for the quarter ending 2025-06-30 was $425.30M, a 4.83% increase year-over-year.
- Avantor, Inc. selling, general and administrative expense for fiscal 2025 was $1.60B, a 2.78% decline from fiscal 2024.
- Avantor, Inc. selling, general and administrative expense for fiscal 2024 was $1.64B, a 8.93% increase from fiscal 2023.
- Avantor, Inc. selling, general and administrative expense for fiscal 2023 was $1.51B, a 2.31% increase from fiscal 2022.
- Avantor, Inc. selling, general and administrative expense for fiscal 2022 was $1.47B, a 3.78% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $401.20M 10-Q · filed 2026-04-29 | $793.60M derived: sum of 2 quarters · filed 2026-04-29 | $1.18B derived: sum of 3 quarters · filed 2026-04-29 | $1.61B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $392.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $782.70M derived: sum of 2 quarters · filed 2026-02-11 | $1.21B derived: sum of 3 quarters · filed 2026-02-11 | $1.60B 10-K · filed 2026-02-11 |
| 2025-09-30 | $390.30M 10-Q · filed 2025-10-29 | $815.60M derived: sum of 2 quarters · filed 2025-10-29 | $1.20B 10-Q · filed 2025-10-29 | $1.57B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $425.30M 10-Q · filed 2025-08-01 | $812.80M 10-Q · filed 2025-08-01 | $1.18B derived: sum of 3 quarters · filed 2026-04-29 | $1.62B derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $387.50M 10-Q · filed 2026-04-29 | $758.90M derived: sum of 2 quarters · filed 2026-04-29 | $1.20B derived: sum of 3 quarters · filed 2026-04-29 | $1.60B derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $371.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $811.20M derived: sum of 2 quarters · filed 2026-02-11 | $1.22B derived: sum of 3 quarters · filed 2026-02-11 | $1.64B 10-K · filed 2026-02-11 |
| 2024-09-30 | $439.80M 10-Q · filed 2025-10-29 | $845.50M derived: sum of 2 quarters · filed 2025-10-29 | $1.27B 10-Q · filed 2025-10-29 | $1.66B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $405.70M 10-Q · filed 2025-08-01 | $829.90M 10-Q · filed 2025-08-01 | $1.22B derived: sum of 3 quarters · filed 2026-02-11 | $1.59B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $424.20M 10-Q · filed 2025-04-25 | $811.30M derived: sum of 2 quarters · filed 2026-02-11 | $1.18B derived: sum of 3 quarters · filed 2026-02-11 | $1.54B derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $387.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $755.50M derived: sum of 2 quarters · filed 2026-02-11 | $1.11B derived: sum of 3 quarters · filed 2026-02-11 | $1.51B 10-K · filed 2026-02-11 |
| 2023-09-30 | $368.40M 10-Q · filed 2024-10-25 | $725.90M derived: sum of 2 quarters · filed 2024-10-25 | $1.12B 10-Q · filed 2024-10-25 | $1.48B derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $357.50M 10-Q · filed 2024-07-26 | $751.10M 10-Q · filed 2024-07-26 | $1.11B derived: sum of 3 quarters · filed 2025-02-07 | $1.49B derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $393.60M 10-Q · filed 2024-04-26 | $756.30M derived: sum of 2 quarters · filed 2025-02-07 | $1.13B derived: sum of 3 quarters · filed 2025-02-07 | $1.48B derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $362.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $737.60M derived: sum of 2 quarters · filed 2025-02-07 | $1.09B derived: sum of 3 quarters · filed 2025-02-07 | $1.47B 10-K · filed 2025-02-07 |
| 2022-09-30 | $374.90M 10-Q · filed 2023-10-27 | $727.00M derived: sum of 2 quarters · filed 2023-10-27 | $1.11B 10-Q · filed 2023-10-27 | $1.54B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $352.10M 10-Q · filed 2023-07-28 | $735.00M 10-Q · filed 2023-07-28 | $1.17B derived: sum of 3 quarters · filed 2024-02-14 | $1.55B derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $382.90M 10-Q · filed 2023-04-28 | $816.40M derived: sum of 2 quarters · filed 2024-02-14 | $1.20B derived: sum of 3 quarters · filed 2024-02-14 | $1.57B derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $433.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $812.20M derived: sum of 2 quarters · filed 2024-02-14 | $1.18B derived: sum of 3 quarters · filed 2024-02-14 | $1.53B 10-K · filed 2024-02-14 |
| 2021-09-30 | $378.70M 10-Q · filed 2022-10-28 | $750.50M derived: sum of 2 quarters · filed 2022-10-28 | $1.10B 10-Q · filed 2022-10-28 | $1.47B derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $371.80M 10-Q · filed 2022-07-29 | $718.30M 10-Q · filed 2022-07-29 | $1.10B derived: sum of 3 quarters · filed 2023-02-14 | $1.42B derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $346.50M 10-Q · filed 2022-04-29 | $723.50M derived: sum of 2 quarters · filed 2023-02-14 | $1.05B derived: sum of 3 quarters · filed 2023-02-14 | $1.38B derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $377.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $706.20M derived: sum of 2 quarters · filed 2023-02-14 | $1.03B derived: sum of 3 quarters · filed 2023-02-14 | $1.37B 10-K · filed 2023-02-14 |
| 2020-09-30 | $329.20M 10-Q · filed 2021-10-29 | $653.20M derived: sum of 2 quarters · filed 2021-10-29 | $996.70M 10-Q · filed 2021-10-29 | $1.33B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $324.00M 10-Q · filed 2021-07-30 | $667.50M 10-Q · filed 2021-07-30 | $996.00M derived: sum of 3 quarters · filed 2022-02-11 | $1.33B derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $343.50M 10-Q · filed 2021-04-28 | $672.00M derived: sum of 2 quarters · filed 2022-02-11 | $1.00B derived: sum of 3 quarters · filed 2022-02-11 | $1.37B derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $328.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $659.30M derived: sum of 2 quarters · filed 2022-02-11 | $1.03B derived: sum of 3 quarters · filed 2022-02-11 | $1.37B 10-K · filed 2022-02-11 |
| 2019-09-30 | $330.80M 10-Q · filed 2020-10-27 | $702.80M derived: sum of 2 quarters · filed 2020-10-27 | $1.04B 10-Q · filed 2020-10-27 | $1.37B derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $372.00M 10-Q · filed 2020-07-29 | $709.60M 10-Q · filed 2020-07-29 | $1.04B derived: sum of 3 quarters · filed 2021-02-16 | $1.39B derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $337.60M 10-Q · filed 2020-04-29 | $670.10M derived: sum of 2 quarters · filed 2021-02-16 | $1.02B derived: sum of 3 quarters · filed 2021-02-16 | $1.39B derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | $332.50M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $679.00M derived: sum of 2 quarters · filed 2021-02-16 | $1.05B derived: sum of 3 quarters · filed 2021-02-16 | $1.41B 10-K · filed 2021-02-16 |
| 2018-09-30 | $346.50M 10-Q · filed 2019-11-05 | $720.10M derived: sum of 2 quarters · filed 2019-11-05 | $1.07B 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $373.60M 10-Q · filed 2019-08-06 | $726.30M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $449.70M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |